EUVIMEDEUVIMED entdecken
Open Access

Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors

Nicole L Inniss, Ján Kozic, Fengling Li, Monica Rosas-Lemus, George Minasov, Jiří Rybáček, Yingjie Zhu, Radek Pohl, Ludmilla Shuvalova, Lubomír Rulíšek, Joseph S Brunzelle, Lucie Bednárová und 12 weitere

ACS Infectious Diseases · 13.10.2023 · 9 (10) · 1918-1931

DOI: 10.1021/acsinfecdis.3c00203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 20.09.2023. Verfasst von Nicole L Inniss und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology-Immunology and Center for Structural Biology of Infectious Diseases, Northwestern University, Feinberg School of Medicine,…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A collaborative, open-science team undertook discovery of novel small molecule inhibitors of the SARS-CoV-2 nsp16-nsp10 2'-O-methyltransferase using a high throughput screening approach with the potential to reveal new inhibition strategies. This screen yielded compound 5a, a ligand possessing an electron-deficient double bond, as an inhibitor of SARS-CoV-2 nsp16 activity. Surprisingly, X-ray crystal structures revealed that 5a covalently binds within a previously unrecognized cryptic pocket near the S-adenosylmethionine binding cleft in a manner that prevents occupation by S-adenosylmethionine. Using a multidisciplinary approach, we examined the mechanism of binding of compound 5a to the nsp16 cryptic pocket and developed 5a derivatives that inhibited nsp16 activity and murine hepatitis virus replication in rat lung epithelial cells but proved cytotoxic to cell lines canonically used to examine SARS-CoV-2 infection. Our study reveals the druggability of this newly discovered SARS-CoV-2 nsp16 cryptic pocket, provides novel tool compounds to explore the site, and suggests a new approach for discovery of nsp16 inhibition-based pan-coronavirus therapeutics through structure-guided drug design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19MiceRatsAnimalsS-AdenosylmethionineMethyltransferases

Stichwörter der Autor:innen

antiviralcoronaviruscovalent inhibitorsnsp16 methyltransferasestructural biology

Substanzen

S-AdenosylmethionineMethyltransferases

Autor:innen und Institutionen

  • Department of Microbiology-Immunology and Center for Structural Biology of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
  • Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, 160 00, Czech Republic.
  • Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
  • WuXi AppTec Co., Ltd, China (Shanghai) Pilot Free Trade Zone, Shanghai, 201308, China.
  • Department of Pharmacology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, United States.
  • Northwestern Synchrotron Research Center, Life Sciences Collaborative Access Team, Northwestern University, Argonne, Illinois 60439, United States.

ORCID-Profile: Erik Andris, Alice Shi Ming Li, Peter J Brown, Edcon Chang, Masoud Vedadi, Karla J F Satchell

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • Takeda Pharmaceuticals International
  • European Regional Development Fund
  • National Institute of Allergy and Infectious Diseases
  • Akademie Ved Cesk? Republiky
  • Ministerstvo Zdravotnictv? Cesk? Republiky

Zitieren

APA

Inniss, N. L., Kozic, J., Li, F., Rosas-Lemus, M., Minasov, G., Rybáček, J., Zhu, Y., Pohl, R., Shuvalova, L., Rulíšek, L., Brunzelle, J. S., Bednárová, L., Štefek, M., Kormaník, J. M., Andris, E., Šebestík, J., Li, A. S. M., Brown, P. J., Schmitz, U., …, & Satchell, K. J. F. (2023). Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors. ACS Infectious Diseases, 9(10), 1918-1931. https://doi.org/10.1021/acsinfecdis.3c00203

Vancouver

Inniss NL, Kozic J, Li F, Rosas-Lemus M, Minasov G, Rybáček J, et al. Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors. ACS Infectious Diseases. 2023;9(10):1918-1931. doi:10.1021/acsinfecdis.3c00203

BibTeX
@article{Inniss2023,
  author = {Inniss, Nicole L and Kozic, Ján and Li, Fengling and Rosas-Lemus, Monica and Minasov, George and Rybáček, Jiří and Zhu, Yingjie and Pohl, Radek and Shuvalova, Ludmilla and Rulíšek, Lubomír and Brunzelle, Joseph S and Bednárová, Lucie and Štefek, Milan and Kormaník, Ján Michael and Andris, Erik and Šebestík, Jaroslav and Li, Alice Shi Ming and Brown, Peter J and Schmitz, Uli and Saikatendu, Kumar and Chang, Edcon and Nencka, Radim and Vedadi, Masoud and Satchell, Karla J F},
  title = {Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors},
  journal = {ACS Infectious Diseases},
  year = {2023},
  volume = {9},
  number = {10},
  pages = {1918--1931},
  doi = {10.1021/acsinfecdis.3c00203}
}
Kostenlos starten →